| 0.2348 -0.046 (-16.35%) | 07-17 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |  |
|||
| Targets | 6-month : | 0.32 |
1-year : | 0.4 |
| Resists | First : | 0.27 |
Second : | 0.34 |
| Pivot price | 0.24  |
|||
| Supports | First : | 0.16 |
Second : | 0.13 |
| MAs | MA(5) : | 0.28 |
MA(20) : | 0.23 |
| MA(100) : | 0.3 |
MA(250) : | 0.54 |
|
| MACD | MACD : | 0 |
Signal : | 0 |
| %K %D | K(14,3) : | 54.9 |
D(3) : | 65.1 |
| RSI | RSI(14): 45.5 |
|||
| 52-week | High : | 1.32 | Low : | 0.16 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ COSM ] has closed above bottom band by 42.4%. Bollinger Bands are 85.9% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 5 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 0.27 - 0.27 | 0.27 - 0.28 |
| Low: | 0.23 - 0.23 | 0.23 - 0.23 |
| Close: | 0.23 - 0.23 | 0.23 - 0.24 |
Cosmos Health Inc. functions as a vertically integrated pharmaceutical firm, providing its own line of branded and generic medicines, nutraceuticals, non-prescription drugs, healthcare and infant products, medical devices, and various other goods. These are distributed via its established channels and an e-commerce marketplace. The company actively seeks, obtains, develops, and commercializes solutions designed to improve patients' well-being and health outcomes. Supporting these operations, it maintains distribution centers in both Greece and the United Kingdom, alongside a dedicated warehousing facility. Its clientele includes wholesale pharmaceutical distributors and independent retail pharmacies. Cosmos Health Inc. was established in 2009 and has its headquarters in Chicago, Illinois.
Sat, 18 Jul 2026
Cosmos Health (COSM) Stock Forecast & Analyst Ratings - Moomoo
Fri, 17 Jul 2026
Cosmos Health repurchases 274,000 shares under buyback program - Investing.com
Fri, 17 Jul 2026
Cosmos Health Share Buyback Expands to 5.11 Million Shares; Continues Open Market Repurchases - GlobeNewswire
Fri, 17 Jul 2026
Cosmos Health Buys Back 274,000 Shares at About 26 Cents Each - Stock Titan
Fri, 17 Jul 2026
Cosmos Health (COSM) Expands Share Buyback Program with Additional Purchases - GuruFocus
Thu, 16 Jul 2026
Price to book forward of Cosmos Health Inc. – NASDAQ:COSM - TradingView
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Drug Manufacturers - Specialty & Generic
|
|
| Shares Out | 62 (M) |
| Shares Float | 34 (M) |
| Held by Insiders | 33.9 (%) |
| Held by Institutions | 5 (%) |
| Shares Short | 4,740 (K) |
| Shares Short P.Month | 890 (K) |
| EPS | -0.67 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.4 |
| Profit Margin | -30.5 % |
| Operating Margin | -12.2 % |
| Return on Assets (ttm) | -18.8 % |
| Return on Equity (ttm) | -92.4 % |
| Qtrly Rev. Growth | 30.7 % |
| Gross Profit (p.s.) | 0.11 |
| Sales Per Share | 1.11 |
| EBITDA (p.s.) | -0.27 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -9 (M) |
| Levered Free Cash Flow | -11 (M) |
| PE Ratio | -0.36 |
| PEG Ratio | 0 |
| Price to Book value | 0.58 |
| Price to Sales | 0.2 |
| Price to Cash Flow | -1.57 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|